{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:04:03Z","timestamp":1770419043246,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10620-022-07579-5","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T15:09:57Z","timestamp":1654614597000},"page":"1016-1025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria"],"prefix":"10.1007","volume":"68","author":[{"given":"Anshuman","family":"Elhence","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivanand","family":"Gamanagatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"7579_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-23018-4_5","volume-title":"Portal Hypertension VI","author":"S Augustin","year":"2016","unstructured":"Augustin S, Pons M, Santos B, Ventura M, Genesc\u00e0 J. Identifying compensated advanced chronic liver disease: when (not) to start screening for varices and clinically significant portal hypertension. In: de Franchis R, ed. Berlin: Springer; 2016; 39\u201349. https:\/\/doi.org\/10.1007\/978-3-319-23018-4_5."},{"issue":"3","key":"7579_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563\u2013576. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020.","journal-title":"J Hepatol."},{"issue":"3","key":"7579_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u2013752. https:\/\/doi.org\/10.1016\/j.jhep.2015.05.022.","journal-title":"J Hepatol."},{"key":"7579_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.022","author":"R de Franchis","year":"2021","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G et al. BAVENO VII - RENEWING CONSENSUS IN PORTAL HYPERTENSION: report of the Baveno VII Consensus Workshop: personalized care in portal hypertension. J Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022.","journal-title":"J Hepatol."},{"issue":"3","key":"7579_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver diseases. Liver biopsy. Hepatology. 2009;49:1017\u20131044. https:\/\/doi.org\/10.1002\/hep.22742.","journal-title":"Hepatology."},{"issue":"4","key":"7579_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/apt.16487","volume":"54","author":"YJ Zhou","year":"2021","unstructured":"Zhou YJ, Gao F, Liu WY et al. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2021;54:470\u2013480. https:\/\/doi.org\/10.1111\/apt.16487.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"7579_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","volume":"74","author":"M Papatheodoridi","year":"2021","unstructured":"Papatheodoridi M, Hiriart JB, Lupsor-Platon M et al. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. J Hepatol. 2021;74:1109\u20131116. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.050.","journal-title":"J Hepatol."},{"issue":"1","key":"7579_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology."},{"key":"7579_CR9","doi-asserted-by":"publisher","unstructured":"Shalimar, Elhence A, Bansal B, et al. Prevalence of non-alcoholic fatty liver disease in India: A systematic review and meta-analysis. Journal of Clinical and Experimental Hepatology. Published online November 25, 2021. https:\/\/doi.org\/10.1016\/j.jceh.2021.11.010","DOI":"10.1016\/j.jceh.2021.11.010"},{"issue":"1","key":"7579_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12664-020-01021-2","volume":"39","author":"A Elhence","year":"2020","unstructured":"Elhence A, Shalimar. Treatment of non-alcoholic fatty liver disease\u2014current perspectives. Indian J Gastroenterol. 2020;39:22\u201331. https:\/\/doi.org\/10.1007\/s12664-020-01021-2.","journal-title":"Indian J Gastroenterol."},{"issue":"11","key":"7579_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","volume":"68","author":"VWS Wong","year":"2019","unstructured":"Wong VWS, Irles M, Wong GLH et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut. 2019;68:2057\u20132064. https:\/\/doi.org\/10.1136\/gutjnl-2018-317334.","journal-title":"Gut."},{"issue":"5","key":"7579_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/jgh.15358","volume":"36","author":"A Anand","year":"2021","unstructured":"Anand A, Elhence A, Vaishnav M et al. FibroScan-aspartate aminotransferase score in an Asian cohort of non-alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery. J Gastroenterol Hepatol. 2021;36:1309\u20131316. https:\/\/doi.org\/10.1111\/jgh.15358.","journal-title":"J Gastroenterol Hepatol."},{"issue":"3","key":"7579_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810\u2013820. https:\/\/doi.org\/10.1002\/hep.24127.","journal-title":"Hepatology."},{"issue":"6","key":"7579_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology."},{"issue":"5","key":"7579_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264-1281.e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036.","journal-title":"Gastroenterology."},{"issue":"6","key":"7579_CR16","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/hep.28824","volume":"64","author":"JG Abraldes","year":"2016","unstructured":"Abraldes JG, Bureau C, Stefanescu H et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study. Hepatology. 2016;64:2173\u20132184. https:\/\/doi.org\/10.1002\/hep.28824.","journal-title":"Hepatology."},{"issue":"1","key":"7579_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10620-012-2306-1","volume":"58","author":"R Kumar","year":"2013","unstructured":"Kumar R, Rastogi A, Sharma MK et al. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci. 2013;58:265\u2013274. https:\/\/doi.org\/10.1007\/s10620-012-2306-1.","journal-title":"Dig Dis Sci."},{"issue":"6","key":"7579_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042.","journal-title":"Gastroenterology."},{"issue":"1","key":"7579_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:156-163.e2. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.043.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7579_CR20","doi-asserted-by":"publisher","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. Published online May 17, 2021:gutjnl-2021\u2013324243. https:\/\/doi.org\/10.1136\/gutjnl-2021-324243","DOI":"10.1136\/gutjnl-2021-324243"},{"issue":"23","key":"7579_CR21","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.3748\/wjg.v20.i23.7392","volume":"20","author":"SS Lee","year":"2014","unstructured":"Lee SS. Radiologic evaluation of nonalcoholic fatty liver disease. WJG. 2014;20:7392. https:\/\/doi.org\/10.3748\/wjg.v20.i23.7392.","journal-title":"WJG."},{"issue":"7","key":"7579_CR22","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898\u20131906. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.084.","journal-title":"Gastroenterology."},{"issue":"4","key":"7579_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5:362\u2013373. https:\/\/doi.org\/10.1016\/S2468-1253(19)30383-8.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"4","key":"7579_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021;75:770\u2013785. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.044.","journal-title":"J Hepatol."},{"key":"7579_CR25","doi-asserted-by":"publisher","unstructured":"Imajo K, Honda Y, Kobayashi T, et al. Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. Published online December 17, 2020:S1542\u20133565(20)31673\u20136. https:\/\/doi.org\/10.1016\/j.cgh.2020.12.016","DOI":"10.1016\/j.cgh.2020.12.016"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07579-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:12:23Z","timestamp":1678684343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07579-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7579"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07579-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}